Friday, August 16, 2024 9:08:01 AM
poor management as they falsely pumped this stock now passing R/S effective Aug. 20
They also know they committed fraud and had to pass = 2. Officer Exculpation Proposal
Item 2 was to approve Article VIII of the Company’s Amended and Restated Certificate of Incorporation to permit officer exculpation (the “Officer Exculpation Proposal”), designated to be voted upon by the holders of Class A common stock and Class B common stock, voting together as a single class. The results of the vote were as follows:
exculpation
noun
a defense of some offensive behavior or some failure to keep a promise etc.
his transparent self-justification was unacceptable
the act of freeing from guilt or blame
They also know they committed fraud and had to pass = 2. Officer Exculpation Proposal
Item 2 was to approve Article VIII of the Company’s Amended and Restated Certificate of Incorporation to permit officer exculpation (the “Officer Exculpation Proposal”), designated to be voted upon by the holders of Class A common stock and Class B common stock, voting together as a single class. The results of the vote were as follows:
exculpation
noun
a defense of some offensive behavior or some failure to keep a promise etc.
his transparent self-justification was unacceptable
the act of freeing from guilt or blame
Recent DNA News
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/13/2026 02:39:52 PM
- The $59B Quiet Shift Reshaping How Patients Access Care • PR Newswire (Canada) • 05/12/2026 02:30:00 PM
- The $59B Quiet Shift Reshaping How Patients Access Care • PR Newswire (US) • 05/12/2026 02:30:00 PM
- Ginkgo Bioworks Reports First Quarter 2026 Financial Results, Completes Divestiture of Biosecurity and Continues to Scale Autonomous Lab • PR Newswire (US) • 05/07/2026 08:05:00 PM
- Ginkgo Bioworks Announces Date of First Quarter 2026 Results Presentation • PR Newswire (US) • 04/30/2026 12:01:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/29/2026 08:18:50 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/29/2026 08:10:26 PM
- Ginkgo Bioworks Launches Ginkgo Cloud Lab, Powered by Autonomous Lab Infrastructure • PR Newswire (US) • 03/02/2026 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2026 02:56:36 AM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 02/26/2026 09:49:34 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/26/2026 09:34:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2026 09:30:45 PM
- Ginkgo Bioworks Reports Fourth Quarter and Full Year 2025 Financial Results, Announces Focus on Autonomous Labs Offerings and Divestiture of its Non-Core Biosecurity Business • PR Newswire (US) • 02/26/2026 09:26:00 PM
- Ginkgo Bioworks Announces Date of Fourth Quarter and Full Year 2025 Results Presentation • PR Newswire (US) • 02/19/2026 01:00:00 PM
- Ginkgo Bioworks and Invaio Sciences Enter Collaboration to Develop Manufacturing Technology for Peptide-based Agricultural Products • PR Newswire (US) • 02/18/2026 01:00:00 PM
- Ginkgo Bioworks' Autonomous Laboratory Driven by OpenAI's GPT-5 Achieves 40% Improvement Over State-of-the-Art Scientific Benchmark • PR Newswire (US) • 02/05/2026 07:00:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/04/2026 02:52:31 PM
- Ginkgo Bioworks Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference • PR Newswire (US) • 01/13/2026 01:00:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/07/2026 03:09:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/23/2025 10:26:04 PM
- Ginkgo Bioworks Partners with Carnegie-Mellon University to Develop Innovative New Cancer Screening Approach • PR Newswire (US) • 12/22/2025 06:21:00 PM
- Ginkgo Bioworks and Agricen Enter Collaboration to Optimize Manufacturing Processes for a Key Agricultural Soil Amendment • PR Newswire (US) • 12/17/2025 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/16/2025 10:11:04 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/15/2025 09:20:50 PM
